Search results
New York Restricts Sale of Weight-Loss and Muscle-Building Supplements to Minors
Insurance Journal· 1 hour agoIt’s now illegal to sell weight-loss and muscle-building supplements to minors in New York, under a...
Weight loss drug shortage: Zepbound and Wegovy in short supply, says FDA
BenefitsPRO· 4 days agoThe U.S. Food and Drug Administration updated its drug shortage database in April to reflect that...
How to Get Prescription Weight Loss Medication Without Insurance
MediaFeed via AOL· 4 days agoWhether you’re on a weight loss journey of your own or not, you probably haven’t been able to avoid...
Weight loss plateau on GLP-1 drugs vs surgery: When does it happen?
Medical News Today· 5 days agoUtilising a mathematical model, the research examines how these interventions alter the body’s...
Web searches for Wegovy side effects spike 3,500%: What to know about the obesity medication and...
Yahoo Canada Style· 2 days agoWegovy contains semaglutide, a medication that was initially developed to treat diabetes but was...
Weight-loss drug coverage for Illinois state workers could cost hundreds of millions of dollars
WBEZ 91.5 Chicago· 6 days agoGov. JB Pritzker’s office pushed to expand coverage of high-priced weight-loss drugs for state...
Why Weight-Loss Drugs Wegovy, Zepbound Are in Short Supply
The Business of Fashion· 3 days agoBoth drugmakers are facing manufacturing challenges that threaten to keep the weight loss...
Weight loss surgery remains important option, even as new meds make headlines
WIBW Topeka· 3 days agoNew weight loss medications are making headlines. While it might have some people wondering if...
Weight loss drug wins 25,000 new US users a week
BBC via Yahoo Finance· 4 days agoIn all, Novo Nordisk said its diabetes and weight loss drugs served almost 42 million patients globally at the end of March. The US, where about 40% of...
Amgen investors await weight-loss drug data
Reuters via AOL· 5 days ago(Reuters) -Amgen investors eyeing dramatic share price gains for rivals with successful obesity drugs will be focused on any updates the biotech company...